Archive for the Birth Control Dangers Category

Birth Control device complaints rise

Posted in birth control, Birth Control Dangers, Planned Parenthood with tags , , , , , , , , , , on January 5, 2011 by saynsumthn

Vodpod videos no longer available.

Birth Control device complaints rise, posted with vodpod

A new Birth Control which can be implanted has come under fire. Implanon, which has been praised by groups like Planned Parenthood, is a long-acting contraceptive implant containing the active ingredient etonogestrel, a synthetic progestogen. According to this article in the Wall Street Journal: Merck Backs Contraceptive Amid Complaints , By STEN STOVALL , Nearly 600 women in the U.K. have become pregnant despite using a contraceptive implant fitted in their arms, and just more than 1,600 women have complained about the device to Britain’s medicines watchdog, including 584 who said they had unwanted pregnancies.

The London-based Medicines and Healthcare Products Regulatory Agency, or MHRA, said Wednesday that it received a total of 1,607 adverse drug reaction reports linked to Implanon since 1999, citing 2,888 suspect reactions that ranged from pain at the point of insertion to subsequent scarring.

The Irish Times today reported that, A total of 32 women in Ireland reported falling pregnant while using a contraceptive implant device, the Irish Medicines Board has confirmed.

After it’s approval by the FDAPlanned Parenthood made this statement about Implanon,

“This method is great news for women who want long-term, reversible birth control and the freedom of not having to remember a pill every day,” said Planned Parenthood Federation of America Vice President for Medical Affairs Vanessa Cullins, MD, MPH. “Planned Parenthood applauds this addition to the array of contraceptive choices for women. Clinicians in our health centers across the country will be trained to provide the new method and soon will start offering Implanon.”

Implanon is a thin, matchstick-sized rod, called an implant. It is made of soft, plastic-like material and contains progestin. It is inserted beneath the skin of the arm and a very small amount of the hormone is released continuously to prevent pregnancy. It is effective for up to three years.

“Planned Parenthood of Houston and Southeast Texas (PPHSET) is excited about this new birth control option that we will soon offer our clients,” said Dr. Paul Fine, medical director for PPHSET. “Implanon is a safe and effective birth control method for women throughout their reproductive lives. Implanon will enable women to prevent unintended pregnancy, to plan and space wanted pregnancies, or to provide reversible, long-term contraception as part of their basic health care.”

Link Found Between Birth Control And Strokes In Kids

Posted in birth control, Birth Control Dangers with tags , , , , , on November 5, 2010 by saynsumthn

November 5, 2010 (RTTNews )
A new report in the journal Acta Paediatrica suggests that children who smoke and take oral contraceptive pills are at an increased risk for stroke.

According to Dr. Sten Christerson of the Paediatric Clinic at the Orebro University Hospital in Sweden, children who suffer strokes early in life often have life long health problems.

“The aim of the study was to evaluate the incidence, presenting symptoms and signs, time lag to diagnosis, medical investigations, risk factors and short-term outcomes of childhood stroke,” Christerson tells ScienceDaily.com.

For the study, Christerson and his team reviewed the health records of children between the ages of 28-days-old and 18-years-old and found that 85 percent of those who survived strokes had significant neurological impairments.

“Although childhood stroke is not as common as many other childhood illnesses, it is a serious condition that results in considerable long-term ill health and severe functional disabilities.”
A significant number of the female patients were using oral contraceptives and/or smoking prior to their stroke. Christerson says that the new data should raise awareness of childhood stroke.

“Clear guidelines are needed to provide more consistent diagnosis and treatment of childhood stroke and our study also highlights the need for long-term rehabilitation services. It also raises real concerns about young girls who take oral contraceptives and also smoke or have iron deficient anaemia.”

Contraceptive Dangers Rising Concern Over Side Effects

Posted in Abortion pill, birth control, Birth Control Dangers with tags , , , , , , , , , , , , , , , , on September 15, 2010 by saynsumthn

Note- This came out in 2005- research has been done to prove further dangers since:

WASHINGTON, D.C., JAN. 8, 2005 (Zenit.org).- Even as governments and family planning groups continue to push contraceptives, new evidence is coming forward on their dangerous side effects. In England, the minister for children, Margaret Hodge, declared that she was in favor of injectable contraceptives for schoolgirls, BBC reported Nov. 16.

“What is really interesting is this contraceptive injection,” she declared. “If people are having sex, you don’t want them to have babies at that age.”

Hodge’s enthusiasm for contraceptives flies in the face of scientific warnings. On Aug. 23 Reuters reported on research by a team from the University of North Carolina and Johns Hopkins University in Baltimore. Women who use the injected contraceptive Depo-Provera have a higher rate of sexually transmitted diseases, they concluded.

Charles Morrison, of Family Health International, said that more study is needed, but it is possible that Depo-Provera itself causes a susceptibility to sexually transmitted diseases. “We did adjust for differences in condom use, differences in multiple partners, differences in the number of sexual coital acts,” he told Reuters.

Depo-Provera is also under scrutiny by the U.S. Food and Drug Administration. The agency has now stipulated that the drug must carry a special warning that prolonged use can cause significant loss of bone density, the Associated Press reported Nov. 17.

Shortly after the FDA announcement, another study confirmed the problem of bone loss due to Depo-Provera, Reuters reported Dec. 23. Researchers from the University of Iowa compared 178 women using the injectable with 145 women not using hormonal contraception.

Average bone density at the hip fell 2.8% one year after starting Depo-Provera and 5.8% after two years. Loss of bone density in the spine was similar. This compares to average bone loss of less than 0.9% among the control group.

Deadly side effects

Another contraceptive with troubling consequences is the so-called patch. Last April 4 the New York Post reported on the case of 18-year-old Zakiya Kennedy, who died as a result of blood clots, formed as a result of her patch contraceptive. She had switched from using birth-control pills to the patch about three weeks before her death.

The newspaper followed this up with a Sept. 19 report tying the Ortho Evra patch, the only kind marketed in the United States, to the deaths of at least 17 women in the past two years. The article added that scores of other women using the patch have suffered complications, including 21 “life-threatening” cases of blood clots and other ailments. The data came from FDA reports obtained by the newspaper.

The article added that the manufacturer claims the patch has been used by 4 million American women since it went on sale in 2002. A company spokesman commented that the illnesses and deaths are “consistent with the health risks” of the pill, which it says kills 0.3 to 1.9 women in every 100,000 users ages 15 to 29.

Concerns over the health risks of another contraceptive forced the FDA to step in a few days ago to correct a TV commercial. Reuters reported Dec. 30 that the FDA warned Barr Pharmaceuticals that its ads for Seasonale pills failed to mention the side effect of frequent and substantial bleeding.

The FDA warned the company that the commercial misleads consumers by excluding this information, to make the birth control pill seem safer. The warning came in a letter to the company released by the FDA on Dec. 29. In addition to the bleeding problems the pill’s label warns that other side effects can include blood clots, heart attack and stroke. But the commercials, observed the FDA, use “compelling visuals” and “fast-paced scene changes” along with other techniques that distract from warning information.

Good news proved false

One recent report at first seemed to disprove health worries over contraceptives. The British newspaper Guardian on Oct. 26 noted that some studies had concluded that the pill could help protect women from heart disease and strokes. Plus, another study of women in America concluded that the pill did not increase the risk of breast or cervical cancer.

These results were presented at the American Society of Reproductive Medicine conference in Philadelphia last October. The data came from the ongoing Women’s Health Initiative (WHI) study, which is tracking a group of more than 160,000 women.

The report in the Guardian was skeptical about the positive news. It noted that the WHI study had previously reported data linking hormone replacement treatment to an increased risk of breast cancer, heart disease and strokes. The contraceptive pill and HRT are practically the same, the article noted.

The doubts proved to be prescient. On Nov. 27 the London-based Times reported that the WHI had subsequently rejected the findings drawn from its data and demanded a retraction.

Jacques Rossouw, acting director of the WHI, admitted to the Times that the study lacked credibility. “The researchers just looked at base-line data, which is very poor data,” he said. “That is why the findings are so bizarre. These kinds of results are just not credible.”

The Times followed this story up with another article, on Dec. 13, that warned of higher stroke risks for women who take the pill. Based on a study of more than 5,000 people, researchers from Canada, the United State and Spain have concluded that migraine sufferers who take the pill are up to eight times more likely to suffer a stroke than those not using it. The Times added that migraines affect an estimated 6 million people in Britain, with women being more susceptible to the problem.

So-called morning-after pills are also associated with health problems. A July 30 report by Medical News Today summarized the findings of a study published by Dr. Gene Rudd in the September issue of the Annals of Pharmacotherapy.

Last July 22, Barr Laboratories reapplied to the U.S. Food and Drug Administration to receive approval for Plan B to be made available over-the-counter, after the FDA’s initial refusal. Rudd’s article contains data arguing that easing access to Plan B would place the health of many women at risk.

Rudd noted that nonprescription access to Plan B would keep many women out of doctors’ offices and away from appropriate, comprehensive care. Additionally, Plan B may encourage more risk-taking behaviors such as “unprotected” sex that increase the spread of sexually transmitted diseases.

Health concerns are not limited to contraceptives. The abortion pill RU-486 has been linked to a number of deaths. A well-known case is the 2003 death of Holly Patterson, an 18-year-old Californian who succumbed to septic shock after taking RU-486.

Holly’s father, Monty Patterson, said that the FDA should ban the abortion pill after a third death was being linked to its use, the Associated Press reported Nov. 16. That same day, the New York Times reported that the FDA has asked that the warning label on the RU-486 be strengthened.

In an opinion article published Nov. 19 in the New York Times, Donna Harrison, an obstetrician-gynecologist and member of the American Association of Pro-Life Obstetricians and Gynecologists, accused authorities of having given the green light to the abortion pill in 2000 due to political interference by the Clinton administration.

She explained that documents recently obtained through the Freedom of Information Act reveal that the Clinton administration “pushed to get RU-486 approved before the 2000 election despite the lack of reliable data demonstrating its safety.” That news may have come too late for at least a few RU-486 users.

Dying for birth control?

Posted in Abortion, Abortion death, Abortion injury, Abortion pill, birth control, Birth Control Dangers with tags , , , , , , , , , , , , , , , , , , , on August 24, 2010 by saynsumthn

Birth Control Death
Aired: 2/17/2010 10:13PM CST

Vodpod videos no longer available.

Birth Control Death, posted with vodpod

Symptoms

Symptoms of gallbladder problems could include:

* Pain or discomfort in the upper right side of the abdomen
* Nausea
* Diarrhea
* Abdominal Bloating
* Jaundice

Symptoms of blood clots could include:

* sudden severe headaches
* unusual swelling or pain in the legs or arms
* sharp or crushing chest pain or coughing blood
* eye problems such as blurred or double vision or complete loss of vision
* pain in the back of the lower leg

YAZ/Yasmin

NPR: With Birth Control Pills, New Isn’t Always Better
by Richard Knox
Bayer HealthCare, the leading maker of birth control pills, is coming out with a brand new pill.

Natazia, as it’s called, contains a form of estrogen that’s never been used in an oral contraceptive. It also has a novel dosing regimen. Women on Natazia will take four different combinations and doses of hormones or sugar pills each month.

The new launch coincides with growing problems for Bayer’s last new contraceptive, Yaz.

Beyond Birth Control

After Yaz came out in 2006, it quickly became America’s No. 1 birth control pill, bringing Bayer $800 million last year. But now thousands of women are suing Bayer because they say Yaz caused them serious harm. Sales have dropped 15 percent in the past year.

It’s a good time to look at the Yaz saga and see if it has anything to teach women and their doctors when they choose a contraceptive.

Yaz was something entirely new in the long history of birth control pills — and not just in its chemical formulation. It was the first pill to be marketed for multiple purposes. Bayer promoted it heavily as going “beyond birth control.”

A centerpiece TV ad noted that “all birth control pills are 99 percent effective and can give you shorter, lighter periods. But there’s one pill that goes beyond the rest. It’s Yaz.”

On the screen, brightly colored balloons floated upward. Each balloon had a label — moodiness, irritability, feeling anxious, increased appetite, bloating, fatigue, headaches, muscle aches, acne. In the background, The Veronicas sang “Goodbye to You.”

A Cautionary Tale
Those ads caught the attention of a 16-year-old in Maryland named Katie Anderson.

“I do remember going to the gynecologist and asking for Yaz because I had seen the commercials,” says Anderson, who’s now 19. “That was the one I wanted.”
Anderson hoped Yaz would even out her irregular periods. She liked the implication that Yaz could treat premenstrual syndrome. And, of course, the idea of clear skin appealed to her, too.

“What girl would not fall for something that says, you know, it’s going to help with moderate or mild acne?” she says. “That’s great! That’s just a perk, that’s a plus.”
So she got her doctor to write a prescription for Yaz. It’s a choice she’d live to regret.

Misleading Ads
We’ll come back to Katie Anderson’s story. But first, let’s hear from professor Ruth Day of Duke University. She advises the Food and Drug Administration on “medical cognition” — people’s comprehension and use of medical information in advertising and drug labels.

Day says she’d never seen a campaign that made such sweeping claims as those Yaz ads. She showed the “balloon” ad to dozens of young women and asked what they thought.

“Most people thought it was going to prevent all those symptoms, period,” Days says.

For instance, 97 percent thought Yaz can treat ordinary PMS.

“It does not,” Day says, noting that the FDA approved Yaz for treating a more serious and less common condition called PMDD — premenstrual dysphoric disorder.
What girl wouldn’t fall for something that says it’s going to help with acne? That’s great. That’s a perk, a plus!

– Katie Anderson
Day also asked her research subjects if they thought Yaz treats mild acne. “Sixty-four percent said, ‘Yes, it does.’ But the truth is, it does not treat mild acne,” she says. “So people were getting this idea that Yaz ‘goes beyond.’ But they were getting the wrong message.”

The FDA agreed. Officials declared the ads misleading and ordered Bayer to run a corrective commercial. But Day found the corrective ad still left a lot of misconceptions about what Yaz can and can’t do.

But there’s no question Bayer’s aggressive ad campaign worked. Yaz catapulted past all other birth control pills — and became Bayer’s top-selling drug.

So one lesson from the Yaz saga is: Be wary of claims that a potent pill will solve all your problems — it’s probably not true. And as Day’s research has found out, all those claimed benefits tend to cloud people’s appreciation of the potential risks.

Consider The Risks
Katie Anderson learned that the hard way. She began having persistent leg pains within a month of starting on Yaz.

“I started developing this kind of pinching, twinging, numbing kind of feeling in my left butt cheek,” she recalls. She thought it was a pinched nerve.
Then a couple of weeks later, she was awakened with terrible chest pain.

“She tells me she woke up about 5 o’clock in the morning,” says Beth Anderson, Katie’s mom. “She sat bolt upright in bed — couldn’t move, couldn’t talk, was trying to cry as silently as possible because it hurt to breathe.”

When she didn’t leave for school on time, Beth went to check on her. “I found her sitting in a puddle of tears saying, ‘Mommy, I can’t breathe! Mommy, I can’t breathe! I couldn’t even reach my cell phone!’ ”

Her doctor diagnosed pleurisy, an inflammation of the chest lining that isn’t serious, and prescribed Motrin. That helped for a while, but over the next few days, Katie developed shortness of breath. And her left leg went totally numb and cold.

“My left leg was completely purple,” she says.

It turns out an enormous blood clot had formed in her leg. A piece of it had broken off and lodged in her lung. Doctors call that a pulmonary embolism, and it can be deadly.

At the emergency room, Beth recalls, “the doctor came in and he took one look at Katie’s cold, blue leg, and he said, ‘Wow! That’s a big blood clot! You’re on birth control, aren’t you?’ “

The link between birth control pills and blood clots isn’t new. It’s been known for decades. Every year a few thousand U.S. women suffer clots because they’re on the pill.
It’s possible that Yaz and Yasmin, a similar pill, carry a higher than usual risk of clotting.

Newest Pills Not Necessarily Safest

Danish researchers decided to compare the experience of millions of women taking different contraceptives. “Denmark is the only country in the world with national registration of all women with thrombotic events [blood clots], whether in public or private hospitals,” says Ojvind Lidegaard of Copenhagen University. “We also have a detailed record of women’s medication history.”

Lidegaard’s group found that women taking Yaz or Yasmin had a 64 percent higher risk of blood clots than women taking pills that have been around for decades. Their study was published late last year in the British Medical Journal.

A 64 percent higher risk is not dramatic. But it’s worrisome, given the fact that millions of women are taking the pills.

“The safest is still, surprisingly, one of the oldest pills,” says Dr. Frits Rosendaal, an expert in clotting disorders at Leiden University in Holland.

Rosendaal led another study that also found that women taking Yaz have a higher risk of clotting than those on older birth control pills — about twice as high. That paper also appeared in the British Medical Journal.

“There are convincing indications this pill is less safe than other pills,” Rosendaal says, adding that there’s really no difference in Yaz’s effect on other menstrual symptoms.

Bayer strongly disagrees. The company wouldn’t make a spokesman available to talk about these issues. In a statement, it said that studies the company funded show its pills are no riskier than other contraceptives.

For its part, the FDA looked at all the studies. It found flaws in the Danish and Dutch results. The agency has commissioned its own study, due out sometime next year. The leader of that study, Dr. Stephen Sidney of Kaiser Permanente Health Care, says his reading of the data so far is that “it’s a bit of a mix,” and that the relative risk of Yaz and Yasmin “is an open question.”

Some Women At Higher Risk

On one point, there’s no controversy. Some women have a much higher risk of clotting and death when they take birth control pills. And most of them don’t know they’re at risk.

Katie Anderson was one of these. She has a “superclotting” gene called Factor V Leiden. In fact, Rosendaal’s group in Leiden discovered it.

The gene makes her 35 times more likely to develop a blood clot when she takes any oral contraceptive. With Yaz, her odds might have been even higher.

Factor V Leiden isn’t rare. Rosendaal says about 1 in 5 Caucasians has it, but it’s not routinely tested for. It turns out Katie’s father has the gene. Beth Anderson says she pointed that out to Katie’s doctor before she went on birth control pills.

“I wanted to make sure that wasn’t going to be an issue,” Beth Anderson says. The doctor, she reports, “said she was not aware there was any specific problem with that.”

The leaflets inside all packets of birth control pills warn women not to take them if they have a family history of clotting. But that’s often not mentioned in TV ads. The ads for Yaz simply warned that women over 35 shouldn’t smoke because that increases the risk of blood clots.

“Both Katie and I assumed that since she was well under 35, she wasn’t overweight, and she had never smoked, that it would be safe,” Beth says. “We assumed wrong.”
Katie is now one of 2,700 or so women suing Bayer over Yaz. Three years later, she’s left with a massive clot in her leg that requires her to wear a compression stocking to prevent swelling. She can’t do many of the things she loved to do, and can’t be on her feet for long. The clot may never go away.

“I have to be patient with myself,” she says. “Maybe I can’t run and I can’t hike for very long, but at least I have my legs. At least I can walk.”
So another lesson is: Women and girls thinking of taking the pill should pay attention to the fine print. Their parents, too, if they’re in the picture. And especially their doctors.

As Katie Anderson puts it: “I want people to understand it’s not just a little pill. I want people to understand the risks, understand what the symptoms of a blood clot are like, and really to take it seriously.”

New Pill On Market
So now, Bayer’s introducing another birth control pill.

This happens over and over again. It’s the way the pharmaceutical business works, especially when there’s an enormous market like the one for birth control pills. (About 13 million American women take them, and 100 million around the world.) To garner market share, companies regularly come up with new formulations and market them as new and improved.

The pressure’s even greater when lawsuits have dimmed the luster of a previous drug, or when a company faces competition from generic versions, as is now true of Yaz.
Dr. Edio Zampaglione, senior director of medical affairs for women’s health care at Bayer, and the official in charge of the company’s latest new pill, says its launch has nothing to do with these economic factors. He says Bayer developed Natazia because women need more contraceptive options.

“Each woman is different, and each woman will feel differently on these different types of hormones and will react differently to them,” Zampaglione says.

To some, that might be an argument for caution. When a new birth control pill comes out, no one really knows how millions of women will react to it. Pre-market studies of Natazia involved only about 3,000 women. The unknowns are even greater when a contraceptive contains hormones and combinations never used before.
Beth Anderson says Katie’s story contains a final lesson for women tempted to take the new pill.

“Really, the moral of the story is that you shouldn’t use the latest and greatest drugs unless there’s some reason that the ones that have been around don’t work for you,” she says.

That’s the philosophy of Rosendaal, the Dutch clotting expert.

“Personally, I would not start using a new drug unless it’s proven to be better,” Rosendaal says. “Because we know that all drugs have side effects, and we also know that for newer ones which have not yet been used by millions of people, the side effects are generally unknown.”

Bayer is monitoring how its new pill is doing in up to 70,000 women. But results of those studies won’t be available for at least five years.

ABC News- Birth Control and Blood Clots (Video here )

READ: After 2 More Deaths, Planned Parenthood Alters Method for Abortion Pill

FDA Says 2 More Women Have Died After Taking Abortion Pill
Agency Is Investigating; 7 Fatalities Now Tied to RU-486

By Marc Kaufman
Washington Post Staff Writer
Saturday, March 18, 2006

The Food and Drug Administration reported yesterday that two more women have died after taking the RU-486 abortion pill, bringing to seven the number of fatalities associated with the drug since it was approved for use in 2000.

The agency said that it was investigating the new reports, provided by the manufacturer of the drug, but so far was not able to confirm any cause of death. In four earlier fatalities of California women who had undergone medical abortions, the victims died of a form of blood poisoning caused by Clostridium sordellii , a common but rarely fatal bacterium.

Opponents of abortion quickly described the FDA advisory as another reason to ban the abortion pill, sold as Mifeprex.

“RU-486 is a deadly drug that is killing pregnant women,” Sen. Jim DeMint (R-S.C.), who has co-sponsored a bill to take the drug off the market pending a review, said in a statement. “This drug should never have been approved, and it must be suspended immediately.”

But supporters said that the pill, which has been used worldwide for years, remains safe.

“To put this in context . . . 560,000 medication abortions have occurred in the United States. We know of seven reported deaths of women who had medication abortions in North America,” Vanessa Cullins, vice president for medical affairs of the Planned Parenthood Federation of America, said in a statement. “At this time, none of those deaths have been directly attributed” to the abortion pill, she said.

Though commonly known as RU-486, this medical abortion actually entails taking two pills. The first, an antiprogestin, binds itself to the wall of the uterus, triggering the shedding of the uterine wall and not allowing the embryo to become implanted. One or two days later, the woman takes another drug — misoprostol — that causes her cervix to soften and dilate so the embryo can be expelled.

As a precaution, Cullins said, Planned Parenthood is changing its policy on how medical abortions should be administered. In the past, many women received misoprostol vaginally, although the FDA had never reviewed or approved that method. Vaginal use is considered to be more effective and has fewer side effects, but Cullins said that her organization would no longer recommend that method.

In its advisory, the FDA pointedly said that the safety and effectiveness of vaginal use of the second drug “has not been established.” It also said that providers of medical abortion and emergency-room staffs should investigate the possibility of blood poisoning whenever women who have taken the drugs come in complaining of nausea, vomiting or weakness unassociated with fever or other signs of infection.

The FDA said yesterday that it did not know whether the clostridium bacteria played any role in the most recent deaths, but the agency did establish that it was present in four earlier fatalities. One other death related to medical abortion was in a woman who had an ectopic pregnancy — a condition where RU-486 is not considered appropriate.

The issue of clostridium infection will be discussed at a public workshop in May hosted by the FDA and the Centers for Disease Control and Prevention. The bacterium has been associated with a small number of deaths and more hospitalizations involving both medical abortions and skin grafts.

The agency’s handling of the seven deaths of women who had undergone medical abortion was criticized by opponents of the drug.

“The FDA has pulled other drugs that have caused fewer deaths and less severe complications than RU-486,” Wendy Wright, president of Concerned Women for America, said in a statement. “Why the double-standard for an abortion drug that is now linked to the deaths of seven healthy women and over 800 other reported complications?”

Opponents of medical abortion filed a citizen’s petition with the FDA soon after the drug was approved for use, but the FDA has never acted on it. In addition, Rep. Roscoe G. Bartlett (R-Md.) introduced a bill in 2003 — called Holly’s Law, after Holly Patterson, an 18-year-old California woman who died following a medical abortion — that would ban use of RU-486. The bill has 79 co-sponsors.

Bartlett said yesterday that the maker of Mifeprex, Danco Laboratories LLC, should pull the drug from the market. If it refuses, he said, the FDA should force its withdrawal.

Birth Control Death

Posted in birth control, Birth Control Dangers, Yaz with tags , , , , on August 24, 2010 by saynsumthn

Birth Control Death
Aired: 2/17/2010 10:13PM CST

Vodpod videos no longer available.

Birth Control Death, posted with vodpod

Birth Control can reduce sex drive, study says

Posted in birth control, Birth Control Dangers with tags , , , , on May 3, 2010 by saynsumthn

More Young Women, 18-30, Report Low Libido

Sexperts Say Women are Stressed; Birth Control and Antidepressants Are Also to Blame
By SUSAN DONALDSON JAMES
April 21, 2010—

Iris, a young woman from North Carolina, can’t understand why she has no sexual desire — she is only 30 and in love.

“It distresses me because I will marry soon and I know this will create a lot of tension in my marriage,” Iris (not her real name) wrote to ABCNews.com.

Iris is one of an increasing number of women in the prime of life and at the height of their fertility who have lost their sexual desire, according to medical experts and a growing body of research.

Stress, depression and bad relationships can contribute to low libido, but often birth control pills or antidepressants are the culprit.

A 2010 study by the International Society for the Study of Women’s Sexual Health found many young women experienced guilt and distress over their sex lives.

A cross-sectional study of 31,000 U.S. females 18 and older published in 2008 in Obstetrics and Gynecology magazine, about 43 percent of women reported sexual problems.

Of those aged 18 to 44, about 10 percent complained about low sexual desire — or what is called hypoactive sexual desire disorder (HSDD), according to the study, Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE).

“It’s a real diagnosis,” said Dr. Carolyn Nemec, a women’s health specialist in the department of family medicine at the Cleveland Clinic. “It’s very surprising and we are missing the boat if we don’t talk about younger women.”

“We always think of it as something that women go through at menopause, but millions of American women are affected,” she said. “It’s a complex issue and women’s libidos are complex.”

In 2002, the American Psychiatric Association categorized HSDD in its Diagnostic and Statistical Manual of Mental Disorders (DSM) as any persistent lack of sexual desire that causes a woman distress.

The disorder was most common in women aged 45 to 64 at 14.8 percent.

It’s not so much the lack of libido that characterizes the disorder, but the amount of anxiety it causes. Even though post menopausal women report less sexual desire, only about 8 percent are diagnosed with HSDD, because they are not distressed, according to the PRESIDE study.

“I think a lot of women are distressed out there and feel bad and think something is wrong with them,” said Nemec. “The younger patients hear so much about menopause and a lot of these women — aged 18 to 30 — don’t feel they have a voice. We need to focus on them.”

Up to 40 percent of all women who have been diagnosed with HSDD also report depression, she said. And for those who are on antidepressants like SSRIs, as many as half can experience a decrease in desire.

Birth Control, Antidepressants Can Cause Low Desire

Birth control pills that contain estrogen and progesterone can also be to blame.

“They increase sex-binding globulin, a protein in the blood stream that binds with our testosterone and testosterone is one of the central hormones in desire,” said Nemec.

When she rules out all other causes of low libido, Nemec will often recommend trying a different antidepressant or decreased dosages. Sometimes, she’ll ask the woman to go on a “drug holiday,” to restart her libido.

For women, sexual desire is a complex psychological and physiological phenomenon.

Some of Nemec’s patients are young women who have just had a baby and trying to reignite desire after a pregnancy. But others are single women in their 20s who began having sex just to keep up with their peers.

“I call it the ‘going along syndrome,'” she said. “By 17 they are sexually active and go along with sex, even if it doesn’t feel good or they don’t have a libido. If they go along at 18 or 20, they continue after they are married.”

The danger is that if they don’t deal with the issues of desire until they are older, “the husband finally gets Viagra at 60 and she’s really in trouble.”

Read Rest of article here

Woman dies from blood clot linked to birth control

Posted in birth control, Birth Control Dangers with tags , , , , , , , , on April 14, 2010 by saynsumthn

Bank worker died of blood clot linked to Pill

4-9-2010 UK Telegraph

A bank worker who took the Pill for ten years was killed by a blood clot thought to have been caused by the contraceptive drug.

Jenna Morris, of Poulton, Wirral, died after a deep vein thrombosis developed in her legs and spread to her lungs.

Before she collapsed Miss Morris complained of shooting pains in her legs and within hours her mother Christine found her daughter’s body at her home in Merseyside.

A post mortem revealed she died of a blood clot, possibly caused by the contraceptive pills which she had been taking since she was a teenager.

Her devastated family today paid tribute to their “beautiful pink princess”.

Just weeks before the tragedy she had been signed-off work with ill health by her doctor who diagnosed kidney stones and prescribed a course of antibiotics.

Miss Morris’ sister Suzanne said: “I’m still in shock. I still cannot believe what happened. I keep thinking it is a terrible dream.

“Jenna was originally told she had kidney stones. She was due to go for a scan but it would not have detected the blood clot, which we were told was possibly caused by the contraceptive pill.

“People should be aware because it could happen to anyone. Jenna was our beautiful pink princess and a fantastic sister. I miss her so much.”

At the time of her death Jenna was planning a wedding to her fiance, Luke Hawson. who proposed to her on her 28th birthday in November last year.

An inquest into Jenna’s death has been opened and adjourned.

Lynn Hearton, Helpline and Information Services Manager, at sexual health charity FPA said: “The pill is an extremely safe method of contraception and fortunately reactions with women developing blood clots are rare.

“However there is a small risk which is highest in the first year of use. So the normal advice for women who have: previously had a blood clot, who are smokers over the age of 35 or who have mobility problems is that they should not use the pill.

“This is why it’s important to discuss your medical history with whoever prescribes your contraception and if anybody is worried, don’t stop using your pill, just seek advice from your health professional or FPA.“